🔴 Bio Green Med Solution is trading 6.5% down today after amended S-4/A filing advanced Future NRG acquisition

Bio Green Med Solution is trading 6.5% down now at $0.84 after the September 11 amended S-4/A registration filing advanced its proposed all-stock acquisition of Future NRG.

• The transaction carries a reported $2 billion headline valuation.
• Future NRG selling shareholders are expected to own more than 99% of the combined company, while existing shareholders retain less than 1%.
• The filing-driven decline outweighs relatively modest broader-market weakness.